Podcasts about pharmd

Guests:

Introducing Melissa Smith, PharmD, CPH, CPGx, Founder of Florida PGX Consulting, and the new host of the Precision Health and PGX Podcast! Dr. Melissa is joined by her guests Dr. Jamie Wilkey & Dr. Jackie Boyle to discuss their introduction to precision medicine in PGX, as well as their friendship that encouraged it!

“We're really using these in many, many types of malignancies. But you can see this class of drug, these monoclonal antibodies, the small molecule inhibitors, being used in colorectal cancer, ovarian cancer, renal cell carcinoma, brain cancers, hepatocellular, non-small cell lung cancer, gynecologic malignancies, so lots of different types of cancers where we're seeing these drugs used,” Danielle Roman, PharmD, BCOP, manager of clinical pharmacy services at the Allegheny Health Network Cancer Institute in Pittsburgh, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the vascular endothelial growth factor (VEGF) inhibitor drug class. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 8, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learner will report an increase in knowledge related to the use of VEGF inhibitors in the treatment of cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 303: Cancer Symptom Management Basics: Ocular Toxicities Episode 244: Cancer Symptom Management Basics: Cardiovascular Complications Episode 196: Oncologic Emergencies 101: Bleeding and Thrombosis Episode 161: Administer Bevacizumab Infusions With Confidence ONS Voice articles: Manage Afatinib's Adverse Events to Keep Patients on Treatment Oncology Drug Reference Sheet: Cabozantinib Oncology Drug Reference Sheet: Fruquintinib Patient Education Needs With Pazopanib Therapy for Soft Tissue Sarcoma ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) Safe Handling of Hazardous Drugs (fourth edition) ONS courses: Safe Handling Basics Clinical Journal of Oncology Nursing article: Safety and Adverse Event Management of VEGFR-TKIs in Patients With Metastatic Renal Cell Carcinoma Oral Anticancer Medication Care Compass: Resources for Interprofessional Navigation ONS Oral Anticancer Medication Learning Library ONS Oral Anticancer Medication Toolkit IV Cancer Treatment Education Sheets Oral Chemotherapy Education Sheets To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Cancer cells are known to secrete factors that cause the formation of new blood vessels, and tumors need blood vessels to supply themselves with nutrients so that they can grow and metastasize. A lot of tumors overexpress these factors, so they had more of this ability to create new blood vessels. You may hear that term somewhere neo vascularization. … And also these factors can increase the permeability of blood vessels, so making them kind of leaky blood vessels. … So the thought behind it is being able to block the ability for this new blood vessel formation and to decrease that leakiness or permeability of those blood vessels.” TS 2:07 “These are drugs that are tyrosine kinase inhibitors. These are oral, small molecule drugs that are acting intracellular, so they are working within the cell to bind and prevent that downstream signaling of producing more blood vessels. So we have a number of small molecule drugs that fall into this class. Many of them target multiple types of receptors, VEGF being included, but also a lot of these drugs have other targets.” TS 7:58 “I would really say, number one, something that we very commonly see with this drug class is hypertension. Giving you an example of bevacizumab—If we look at any grade hypertension, this can be up to 67% of patients, so very common toxicity really spanning all of these agents. So something that we need to be monitoring closely for.” TS 13:24 “With that impaired wound healing, keeping that in mind, as we are planning for this agent, for patients and even sometimes with the minor surgical procedures, maybe a need for a short hold, and even for something like a catheter placement. I know and some of the providers I work with have a preference for holding for a short period of time around that as well.” TS 20:15 “I think one big area, and we've seen some of this just recently, and particularly in the hepatocellular setting, we're seeing combinations of using the VEGF inhibitor class with immunotherapy. And so I think we're going to continue to see that evolve. Even hearing about some bispecific antibodies that are in development, where they are targeting VEGF as well as PD-L1, so getting the immunotherapy and VEGF effects.” TS 24:44

It was truly an honor and a great pleasure to talk to a well-respected colleague and friend about his experience as both a pharmacist and an expert in the natural products field. He is a true embodiment of the Myth, Man and Legend. Tune in to learn more about filling in the gaps in the current healthcare climate by utilizing evidence-backed nutraceuticals. Dr. Jeffery A. Johnson, ND, PharmD, RPh, MBA is a dedicated healthcare professional and 30-year combat veteran of the U.S. Armed Forces (USAF). A graduate of Purdue University (BS-Pharm, 1978), he later earned his Doctor of Naturopathy (2000), Doctor of Pharmacy from the University of Kansas (2003), and an MBA. Throughout his career, Dr. Johnson has spent over three decades educating and consulting with healthcare professionals and clients on the integration of nutraceuticals into personal healthcare practices—highlighting both their benefits and potential challenges. Since retiring from active military service in 2017, he has continued his mission of promoting informed, holistic healthcare practices. He currently works part-time as a self-employed Consultant Pharmacist, offering expert guidance on nutraceuticals and overall wellness strategies. Connect with Jeffery via: Email: ntrxpathconsultants@outlook.com Linked In: Dr Jeffery A (Doc Pappy J) Johnson Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Anticipating and managing CDK4/6 inhibitor toxicities in HR+ HER2- breast cancer is essential to improving patient quality of life and optimizing clinical outcomes. In this episode, CANCER BUZZ speaks with Diana Van Ostran, PharmD, BCOP, clinical pharmacy specialist – breast clinic at Miami Cancer Institute, Baptist Health South Florida, about strategies to monitor and manage treatment-related adverse events in patients with early-stage and metastatic breast cancer receiving CDK4/6 inhibitors. She discusses the importance of individualized care and robust patient education around lifestyle and dietary techniques to improve tolerance of this treatment.   Diana Van Ostran, PharmD, BCOP  Clinical Pharmacy Specialist – Breast Clinic Miami Cancer Institute Baptist Health South Florida  Miami, FL   “Clinical pharmacists play a vital role in managing the patient's treatment. Because, as we know, if you're having excessive side effects, patients are going to be less likely to take their medications.”   Resources: ACCC Adverse Event Management for CDK Inhibitors in HR+ Breast Cancer ACCC CDK Inhibitors Management Miami Cancer Institute ACCC Spotlight on Miami Cancer Institute: The Role of a Breast Cancer Clinical Pharmacy Specialist for CDK4/6 Inhibitor Management

ASHP's senior education director, Cindy Von Heeringen is joined by John Armitstead, vice president of Pharmacy Services at Lee Health, Jeffrey Reichard, system executive director at UNC Health, and Amy Gutierrez, chief pharmacy officer at John Muir Health, as they discuss their upcoming Midyear session that focuses on applying leadership strategies for system-level pharmacy leaders to generate value within a health system.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Send us a textSchedule an Rx AssessmentSubscribe to Master The MarginTechnology, retaining talent, filling needs in your community. We cover it all and more in this sit down with Dr. Hashim Zaibak, PharmD, Founder and CEO of Hayat Pharmacy.In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, and Bonnie Bond, CPA, sit down with Hashim Zaibak, PharmD, to discuss:- The future of AI in pharmacy- Why communication is the most underrated hiring skill- The hidden impact of pharmacy deserts on urban communities- And more!More About Our Guest: Dr. Jay Phipps is a Pharmacy Gladiator, Pharmacy Doctor, Founder, Entrepreneur President, and CEO with over 29 years of experience in pharmacy. At Phipps Pharmacy, Dr. Jay leads a team of dedicated and professional Pharmacy Doctors and technicians who provide personalized and high-quality care for patients. Phipps Pharmacy, Inc. is an independent pharmacy with 5 locations in Tennessee and Mississippi. Dr. Jay is also the President and CEO of PhippsCare that focuses on Pharmacy Doctor provided healthcare and Health Insurance Solutions who specializes in medical and pharmacy plans for seniors. Dr. Jay currently serves on multiple Boards of Directors and committees on the national, state, and local levels. He has served as the American Pharmacist Association-Academy Students of Pharmacy National President, on the APhA Board of Trustees, President of the Tennessee Pharmacists Association (TPA), on the Board of Directors for TPA, Chair, Tennessee Pharmacy Research Education Foundation, Co-Chair, Carroll County Drug Prevention Coalition and a District 8 County Commissioner. Dr. Phipps received a Doctor of Pharmacy degree from The University of Tennessee Health Science Center, where he also completed a residency in Drug Information and Pharmacotherapy and is currently pursuing an MBA with a major in Leadership and Strategy from the #1 ranked online MBA program at Indiana University - Kelley School of Business.  Dr. Phipps plans to graduate in the fall of 2024. Connect with Dr. Jay Phipps, PharmD, MBA and Greco De Valencia below: Jay Phipps LinkedInPharmacy Gladiator WebsitePharmacy Gladiator InstagramPharmacy Gladiator TikTokPharmacy Gladiator Twitter (X)Greco's LinkedIn Live Oak Bank WebsiteStay connected with us:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterMore Resources on these Topics:Podcast – The One Big, Beautiful, BillPodcast - Momentum on the Hill: Protecting Independent Pharmacies Through AdvocacyPodcast - The Trusted Pharmacist: Advocacy and Building a Resilient Pharmacy

Hashim Zaibak, PharmD, joined Over the Counter to discuss the overall role of pharmacists in administering vaccines and how community pharmacies in particular have stepped up in a big way.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sairah Ahmed, MD The treatment landscape for relapsed/refractory (R/R) large B-cell lymphoma has significantly shifted, with CAR T-cell therapies now offering curative potential in the second-line setting. But these advances also raise important questions, like how to identify the right candidates and navigate logistical barriers to ensure timely, equitable access. Joining Dr. Charles Turck to explore these critical considerations is Dr. Saira Ahmed, Associate Professor in the Department of Lymphoma and Myeloma and the CAR T Program Director in the Department of Lymphoma and Myeloma at the MD Anderson Cancer Center.

Brandon Allen is a North Carolina local with a working-class background and an entrepreneurial spirit that has fueled his journey across multiple industries. He got his start working on farms and in tobacco warehouses before earning his PharmD from the University of South Carolina in 2012. After relocating to Fort Worth, Texas, he took on various roles in pharmacy before purchasing a community retail pharmacy in 2016.Business ownership brought both challenges and growth. By 2021, Brandon was on the verge of bankruptcy—but through perseverance, mentorship, and faith, he turned things around and made the business profitable again. Along the way, he realized his true passion lay elsewhere. In 2023, he sold the pharmacy and went all-in on Masterpiece Construction—a remodeling company committed to breaking industry stereotypes. The company quickly gained traction, generating over $1.1 million in revenue in its first full calendar year and continuing to grow. His story is one of perseverance, reinvention, and boldly pursuing purpose through each new chapter.Brandon's Links:Website: http://masterpiececonstructiontx.comFacebook: facebook.com/masterpiececonstructiontxInstagram: instagram.com/masterpiececonstructiontxLinkedIn: https://www.linkedin.com/in/brandondallen/Freebie: https://masterpiececonstructiontx.com/cost-guide-glpBook Recs:Profit First: Transform Your Business from a Cash-Eating Monster to a Money-Making Machine: https://amzn.to/4cakv6LBusiness Made Simple: 60 Days to Master Leadership, Sales, Marketing, Execution, Management, Personal Productivity and More: https://amzn.to/4c7eI1TBuilding a StoryBrand 2.0: Clarify Your Message So Customers Will Listen: https://amzn.to/4j50lxfThat Will Never Work: https://amzn.to/4hMIyKcPodcast Recs:The School of Greatness: https://podcasts.apple.com/us/podcast/the-school-of-greatness/id596047499Remodelers on the Rise: https://podcasts.apple.com/us/podcast/remodelers-on-the-rise/id820960206Men in the Arena: https://podcasts.apple.com/us/podcast/men-in-the-arena-christian-mens-podcast/id1144237071The Impatient Entrepreneur's links:Facebook: https://www.facebook.com/TheImpatientEntrepreneurPod⁠LinkedIn: https://www.linkedin.com/company/theimpatiententrepreneurpod/⁠Instagram: https://www.instagram.com/theimpatiententrepreneurpod/YouTube: https://www.youtube.com/@TheImpatientEntrepreneurPod⁠Online: https://www.theimpatiententrepreneurpod.comConnect with us⁠⁠: https://www.theimpatiententrepreneurpod.com/contact⁠Kwedar & Co.'s links:Facebook: https://www.facebook.com/kwedarco⁠LinkedIn: https://www.linkedin.com/company/kwedarco⁠Instagram: https://www.instagram.com/kwedarco⁠YouTube: https://www.youtube.com/@KwedarCo⁠Online: www.kwedarco.comConnect with us: https://www.kwedarco.com/book-consultation

Could the food your eating be quietly harming your brain, leading to memory issues, brain fog, and mood swings? In this episode of Better Health Bookshelf, Mike Capuzzi speaks with Dr. Deanna Kelly, an internationally recognized research scientist, and co-author of the new book, Get Your Brain Off Grain, about the powerful gut brain connection and how gluten sensitivity can affect mental and neurological health.Listeners will learn: How a gluten-free diet can improve mental clarity and focus. The link between the mind gut connection and issues like anxiety and depression. Practical steps to improve mental health with a gluten-free lifestyle.Press play to discover if removing gluten could be the missing key to protecting your brain and boosting your mental wellness.Want to explore the science and actionable steps in detail? Click here to get your copy of Get Your Brain off Grain today.If you find this episode helpful, please consider subscribing and sharing it with friends and family.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Neil M. Iyengar, MD Due to their wild-type inhibition, first-generation PIK3CA inhibitors for HR+/HER2- advanced breast cancer were limited by significant toxicities, including hyperglycemia, rash, and diarrhea. But now, mutation-specific PIK3CA inhibitors could help improve tolerability and adherence as well as simplify dosing strategies—all while maintaining efficacy. To learn more about the efficacy and safety of current and emerging PIK3CA-targeted therapies, Dr. Charles Turck speaks with Dr. Neil Iyengar, Co-Director of the Breast Oncology Program and Director of Cancer Survivorship Service at Winship Cancer Institute at Emory University.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Neil M. Iyengar, MD Guest: Komal Jhaveri, MD, FACP The second-line treatment of HR+/HER2-advanced breast cancer has evolved in recent years, particularly with the rise of biomarker-driven strategies targeting PI3Kα and other mutations. But given these advances, there's a lot we need to think about when selecting therapy, like the differences between selective and non-selective inhibitors, toxicity profiles, and shared decision-making. Joining Dr. Charles Turck to share their insights on those key considerations and how we can personalize care for patients with PI3Kα-mutated HR+/HER2- advanced breast cancer are Drs. Komal Jhaveri and Neil Iyengar. Dr. Jhaveri is the section head for the Endocrine Therapy Research Program in the Breast Medicine Service at Memorial Sloan Kettering Cancer Center, and Dr. Iyengar is the Co-Director of the Breast Oncology Program at the Winship Cancer Institute at Emory University.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Hope S. Rugo, MD, FASCO Not only is PI3Kα the most common mutation seen in patients with HR+/HER2- advanced breast cancer, but it's also associated with endocrine therapy resistance and more aggressive cancer growth. Given its prevalence and impact on outcomes, it's important to know how and when to test for this mutation and how emerging targeted therapies might change our approach in clinical practice. Joining Dr. Charles Turck to share her insights on PI3Kα testing and targeted therapies for HR+/HER2- advanced breast cancer is Dr. Hope Rugo, Director of the Women's Cancers Program, Division Chief of Breast Medical Oncology and Professor of the Department of Medical Oncology and Therapeutics Research at City of Hope Comprehensive Cancer Center.

On this episode, we provide an overview of insulin. We discuss the various insulin products available, basal vs prandial insulin, and dosing strategies. We also review clinical concepts such as overbasalization.  Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

We're diving into the first-ever treatment that can delay the onset of type 1 diabetes—Tzield—and hearing from two powerful voices helping spread the word about screening. First, Pelaton star Robin Arzon shares her personal journey - managing diabetes through marathons, pregnancy, and parenting—and why she believes time and information are two of the most valuable tools in diabetes care. We're also going to learn more about Tzield itself from Dalila Masic, PharmD. We're talking about how this works now, who its for, and the future of prevention. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. More about Tzield here Robin Arzon and Barbie video here  Join us at an upcoming Moms' Night Out event! Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

Health care is constantly evolving, especially in the realm of medical pharmacy. Prime Therapeutics (Prime) has been tracking that evolution for 15 years through its annual Medical Pharmacy Trend Report, where Prime experts examine trends, analyze data and share drug forecasts to help health plans and health care leaders make the best prescribing and coverage decisions.   In the most recent episode of the Pharmacy Friends podcast, host Maryam Tabatabai, PharmD, vice president of clinical information, sat down with three leading experts — Kristen Reimers, senior vice president of specialty clinical solutions; Lisa Polakowski, director of the Medical Pharmacy Trend Report; and Ben Messerli, actuarial manager — to reflect on the history and future of this cornerstone report.Stay tuned for the release of the Medical Pharmacy Trend Report this fall. Follow us on our website and social channels.https://www.primetherapeutics.comNewsroom LinkedIn"Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.Other ways to listen:Amazon Music | Apple | Spotify

On July 31, 2025, Eli Lilly and Company announced topline data from the SURPASS‑CVOT trial comparing tirzepatide (Mounjaro) to dulaglutide (Trulicity) in adults with type 2 diabetes and established atherosclerotic cardiovascular disease (ASCVD). According to the data, tirzepatide met the primary non‑inferiority endpoint for 3-point major adverse cardiovascular events (MACE) (hazard ratio [HR], 0.92; 95.3% CI, 0.83 to 1.01), while also showing additional benefits in A1C, weight reduction, renal preservation, and a 16% reduction in all‑cause mortality (HR, 0.84; 95.0% CI, 0.75 to 0.94). In the latest episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, unpacked the top-line results of the SURPASS-CVOT trial. Eli Lilly and Company owns both drugs, which belong to the incretin class, but tirzepatide is a dual GIP/GLP-1 receptor agonist, while dulaglutide is a GLP-1 RA. The trial included over 13,000 adults with type 2 diabetes and either established cardiovascular disease or at high risk. During a median follow-up of 4.5 years, the primary endpoint, which was a composite of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke, was reduced by 8% in the tirzepatide group relative to dulaglutide. However, the result did not reach statistical superiority due to the confidence interval crossing unity. Isaacs and Bellini also highlighted significantly greater A1c (-1.73% vs -0.9%) and weight loss (12% vs 4.95%) with tirzepatide. Additional prespecified analyses comparing data with the placebo-controlled REWIND trial suggest tirzepatide could offer up to 28% MACE and 39% mortality risk reduction compared to theoretical placebo—findings that hint at broader cardiometabolic benefit. Before concluding, hosts speculated about the potential subgroup analyses of interest for the trial, including heart failure and renal outcomes, as well as a brief discussion around Eli Lilly and Company's intent to submit a regulatory application for a cardiovascular indication before the close of 2025. Relevant disclosures for Isaacs include Eli Lilly and Company, Novo Nordisk, Sanofi, Abbott Diabetes Care, Dexcom, Medtronic, and others. Relevant disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and others. References: Eli Lilly and Company. Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease. July 31, 2025. Accessed July 31, 2025. https://investor.lilly.com/news-releases/news-release-details/lillys-mounjaro-tirzepatide-gipglp-1-dual-agonist-demonstrated

During a recent conversation, Dr. Bela Mehta, Chair of the Division of Pharmacy Practice and Science at The Ohio State University College of Pharmacy, shared her insights on the vital role of community pharmacists. The discussion highlighted the challenges faced during the COVID pandemic, including increased patient care demands and immunization efforts, which contributed to rising levels of burnout among pharmacy practitioners. Dr. Mehta reflected on her personal journey, beginning with her father's immigration from India to the U.S. in the 1960s, her childhood in India, and her eventual return to the U.S. Her early experiences working in a community pharmacy sparked a passion for the profession, reinforcing her commitment to patient care. Her academic path, including earning a PharmD and completing a residency, led her to academia, where she now focuses on training future pharmacists and advancing equitable healthcare access. The conversation explored the evolving landscape of pharmacy education and the need for innovative approaches to prepare students for modern challenges. Dr. Mehta emphasized the systemic issues affecting the profession post-pandemic, including workforce shortages and mental health strains on pharmacists. She discussed ongoing efforts to address burnout, improve working conditions, and foster collaboration among healthcare teams to enhance both provider well-being and patient outcomes. Dr. Mehta also shared her interest in complementary and alternative medicine, challenging conventional perspectives within the field. Her approach underscores the importance of evidence-based, patient-centered care that respects diverse needs and preferences. To conclude, Dr. Mehta offered valuable advice on mentorship, leadership, and finding purpose in one's career. She stressed the importance of recognizing achievements and maintaining a balance between personal and professional growth. The discussion reinforced the essential role pharmacists play in healthcare and the ongoing need to support their contributions to community health. -+=-+=-+=-+= Join the Conversation! We want to hear from you! Do you have additional thoughts about today's topic? Do you have your own Prescription for Success? Record a message on Speakpipe   Unlock Bonus content and get the shows early on our Patreon Follow us or Subscribe: Apple Podcasts | Google Podcasts | Stitcher | Amazon  | Spotify --- There's more at https://mymdcoaches.com/podcast Music by Ryan Jones. Find Ryan on Instagram at _ryjones_, Contact Ryan at ryjonesofficial@gmail.com Production assistance by Clawson Solutions Group, find them on the web at csolgroup.com

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Matthew Lunning, DO, FACP Despite FDA approvals and growing clinical integration, CAR T-cell therapies remain clouded by misconceptions, some of which could impact clinical decision-making and delay appropriate referrals. To help set the record straight on CAR T-cell therapy, Dr. Charles Turck speaks with Dr. Matthew Lunning about the realities of patient selection, safety, and access. Dr. Lunning is an Associate Professor in the Division of Hematology/Oncology at the University of Nebraska Medical Center.

Listen in as we explore the latest pharmacologic strategies for HIV prevention—before and after exposure. Our expert panel breaks down key considerations for PrEP and PEP, including indications, drug selection, dosing, and monitoring.Special guest(s):Caitlin Prather, PharmD, BCACP, AAHIVPClinical Pharmacy Specialist, Ambulatory CareInova Health SystemMichael A. Deaney, PharmD, AAHIVPInfectious Diseases Clinical PharmacistChildren's Hospital ColoradoYou'll also hear practical advice from TRC's Editorial Advisory Board member:Andrea Darby-Stewart, MDAssociate Director, Honor Health Family Medicine Residency ProgramClinical Professor of Family, Community & Occupational MedicineThe University of Arizona College of Medicine - PhoenixFor the purposes of disclosure, Dr. Prather reports a relevant financial relationship [HIV PrEP] with Viiv Healthcare (speakers bureau).The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in June 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Checklist: HIV Pre-Exposure Prophylaxis (PrEP)Checklist: HIV Postexposure Prophylaxis (PEP) ChecklistSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Tim Ulbrich, PharmD, breaks down student loan updates from the Big Beautiful Bill, including key changes, how we got here, and what it means for your repayment strategy. Episode Summary In this episode, YFP Co-Founder & CEO, Tim Ulbrich, PharmD breaks down recent student loan updates stemming from the newly passed Big Beautiful Bill. With so many repayment options, formulas, and acronyms flying around, it's more confusing than ever for borrowers to make confident decisions. Tim walks through: ✅ Key changes included in the Big Beautiful Bill ✅ How we got here and why this matters ✅ What these updates could mean for your personal repayment strategy Since this topic can become complex quickly, Tim shares slides in the YouTube video. If you want to follow along visually, be sure to check out the full episode on YouTube. Mentioned on the Show Studentaid.gov Watch This Episode on YouTube  Your Financial Pharmacist  

Michael Murphy, PharmD, MBA, joined Over the Counter to discuss the growing concerns surrounding pharmacy deserts that are spanning across thousands of communities in the US.

In this episode, YARAL Pharma CEO, Stephen Beckman joins clinical sports pharmacist Jessica Beal, PharmD. to discuss an important topic for athletes and active individuals – the role topical NSAID patches can play in acute pain management. Listeners can visit www.YARALPharma.com to learn more about the company and its products or connect on LinkedIn.    Diclofenac Epolamine Topical System 1.3%    Diclofenac Epolamine Topical System 1.3% is a nonsteroidal anti-inflammatory drug (NSAID) used for treating acute pain from minor strains, sprains, and bruises in adults and children aged 6 and older.     Serious side effects may include increased risk of cardiovascular and gastrointestinal (GI) events. NSAIDs can raise the risk of heart attack, stroke, gastrointestinal bleeding, ulceration, and perforation of the stomach and intestines, which can be fatal. The risk for serious cardiovascular events may occur early in treatment and may increase with duration of use. Elderly patients and those with a history of peptic ulcer disease or GI bleeding are at higher risk for serious GI events.    Do not use in patients who are allergic to diclofenac or any of its ingredients, or have a history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Do not use in the setting of coronary artery bypass graft surgery. Avoid use on broken skin. Discontinue immediately if signs of hypersensitivity occur.      Patients should be informed about the warning signs and symptoms of liver problems. Discontinue use if abnormal liver tests persist or worsen or if signs of liver disease develop. Avoid using Diclofenac Epolamine Topical System 1.3% in patients with severe heart failure unless the benefits are expected to outweigh the risks.    The most common side effects include itching, nausea, and headache. Patients should stop use and consult their doctor at the first sign of skin rash or other signs of sensitivity.    Patients should ask their doctor if Diclofenac Epolamine Topical System 1.3% is right for them. For more information and Full Prescribing Information including Boxed Warning and Important Safety Information, visit www.yaralpharma.com   Dr. Beal is not affiliated with YARAL Pharma. All views and opinions regarding pain management are solely her own and are not attributable to YARAL or the Pharmacy Podcast Network. 

The Vizient Summer 2025 Spend Management Outlook (SMO) provides an integrated perspective on trends, factors and future expenses providers will face across the various dimensions of healthcare. In this episode, Dr. Carina Dolan and Dr. Jeni Hayes join host Carolyn Liptak to discuss pharmacy insights from the SMO including declining drug price inflation and how autoimmune conditions have surpassed oncology in total pharmacy costs. They also touch on pediatric spend drivers, biosimilar competition, and the impact of novel therapies. Tune in to VerifiedRx for practical insights to help pharmacy leaders plan for what's ahead.   Guest speakers:  Carina Dolan, Pharm. D., MS Pharm, BCOP   Associate Vice President, Clinical Oncology, Pharmacoeconomics and Market Insights   Vizient    Jeni Hayes, PharmD, MS Pharm, BCPS  Senior Clinical Manager, Market Intelligence  Vizient     Host:   Carolyn Liptak, , BS Pharm, MBA  Verified Rx Host    Show Notes:  [01:13-02:41]  Key pharmacy trends emerging from the Summer SMO [02:42-04:00] Current pharmacy trends [04:01-05:55]  Pharmacy spend for autoimmune conditions has exceeded that of oncology [05:56-07:36] Key takeaways [07:37-08:47] Significant trends in this latest therapeutic insights update [08:48-10:04] Challenges in gene and cell therapy space [10:05-11:33] The Therapeutic Insights webpage for pediatrics [11:34-13:41] Other reflections from the SMO [13:42-14:49]  How to locate the SMO   Links | Resources:  Vizient Spend Management Outlook Vizient Therapeutic class insights   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed  

Kevin Chen, PharmD, MS, BCOP, CPP, and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the new approved drug taletrectinib.

In this episode of the Society of Critical Care Medicine (SCCM) Podcast, host Marilyn N. Bulloch, PharmD, BCPS, FCCM, speaks with Christy C. Forehand, PharmD, BCCCP, FCCM, about retaining highly skilled pharmacists in the ICU setting. Dr. Forehand, a clinical pharmacy specialist and residency program director at Augusta University Medical Center and the University of Georgia College of Pharmacy, shares evidence-based insights and personal reflections on how pharmacist retention directly impacts quality and safety in patient care. The conversation highlights growing concerns around burnout and attrition among ICU pharmacists, underscoring how their involvement improves clinical and economic outcomes—ranging from medication safety and reduced ventilator days to optimized transitions of care. Drawing on American College of Clinical Pharmacy (ACCP) publications and American Society of Health-System Pharmacists (ASHP) guidance, Dr. Forehand outlines strategies for building retention plans that prioritize recognition, advancement opportunities, career mentorship, and structural supports such as protected administrative time. She emphasizes how institutional practices such as improved scheduling, remote work models, and role-specific stipends can prevent burnout while reinforcing team trust and efficiency. Resources referenced in this episode: SCCM's Leadership, Empowerment, and Development (LEAD) Program, which supports professional development Rewards, Recognition, and Advancement for Clinical Pharmacists (Bondi DS, et al. J Am Coll Clin Pharm. 2023;6:427-439)

Dr. Ashley Walker talks about the chapter she wrote for the book, Expanding Your Brilliance: Creating Effortless Abundance while Navigating Business and Motherhood. It's a collection of chapters written by Pharmacist Moms and published by Dr. Christina Fontana, who is also a Pharmacist Mom.    If you're thinking of writing a book, Ashley might inspire you to start your writing journey with a single chapter too. Click to find Expanding Your Brilliance https://amzn.to/418hdwx.   The FULL show notes with links to previous episodes of The Pharmacist Authors Series on https://thepharmacistsvoice.com/podcast.   During our interview, Ashely talks about… Why she accepted the challenge to write/publish Advice for pharmacist authors Her father's impact on her life The challenges of being a wife, mom, pharmacist, advocate, and entrepreneur Her involvement with Atomic Hands.  How personal stories about our unique abilities (like Ashley being a deaf person) can inspire others   If you know a pharmacist who might be is interested in reading Expanding Your Brilliance please share this episode with them.  If you like this podcast, please subscribe to or follow The Pharmacist's Voice ® Podcast on your favorite podcast player and YouTube to get each new episode right when it comes out.   Links from this episode amazon.com link for Expanding Your Brilliance: Creating Effortless Abundance while Navigating Business and Motherhood https://amzn.to/418hdwx  ⭐️⭐️⭐️⭐️⭐️ Dr. Ashley Walker on LinkedIn http://linkedin.com/in/drawalker Dr. Ashley Walker on Facebook: facebook.com/drawalker21 Dr. Ashley Walker on Instagram: @deafpharmd https://www.instagram.com/deafpharmd/  Email Dr. Ashley Walker ashley@drashleyrwalker.com  Atomic Hands https://atomichands.com/  The Pharmacist's Voice Podcast Episode 173 (August 2022) featuring Dr. Ashley Walker  The Pharmacist's Voice Podcast Episode 197 (January 2023) featuring Dr. Ashley Walker   Dr. Christina Fontana, The Pharmacist Coach, on LinkedIn https://www.linkedin.com/in/dr-christina-fontana-transformational-business-coach-56367355/    2025 Pharmacist Authors Series Part 1 of 3 (June) Episode 336 with Jerry Levin, PhD, LMT - Affirm Yourself: 15 Principles to Retrain the Voice in Your Head.   2024 Pharmacist Authors Series Part 1 of 3 (June) Episode 282 with Steve Leuck, PharmD - A Pharmacist's Story An Authentic Tale of True Love, Family, Addiction, and the Practice of Pharmacy Part 2 of 3 (July) Episode 288 Helen Sairany, PharmD - The We You Don't See:  Understanding the Long Shadows of Trauma Part 3 of 3 (August) Episode 293 Kim Newlove with Publishing in Doses Co-Founders Janan Sarwar, PharmD and Theary Chhim, PharmD plus audio engineer, Julie Walthers.    2023 Pharmacist Authors Series (Part 1 of 15) June 5, Introduction to the Pharmacist Authors Series (Episode 220) (Part 2 of 15) June 9, The Pharmacist's Voice ® Podcast Episode 221:  Interview with Salam Kabbani, PharmD about her book: COVID Long-Hauler:  My Life Since COVID (Part 3 of 15) June 12, The Pharmacist's Voice ® Podcast Episode 222:  Interview with audio engineer Julie Walthers from Whole Story Studio: https://www.wholestorystudio.com/  (Part 4 of 15) June 16, The Pharmacist's Voice ® Podcast Episode 223 Interview with Erin L. Albert, PharmD on her book The Life Science Lawyer Part 5 of 15) June 19, The Pharmacist's Voice ® Podcast Episode 224 Interview with Sue Ojageer, PharmD on her children's book The Pharma Heroes:  The Power of Precision Medicine (Part 6 of 15) June 23, The Pharmacist's Voice ® Podcast Episode 225: Interview with Tony Guerra, PharmD about his Pharmacist Residency and Career Series (8 books) (Part 7 of 15) June 26, The Pharmacist's Voice ® Podcast Episode 226:  Interview with Christina Fontana, PharmD about her book Moving Beyond the Counter:  Elevating into Heart-Centered Health Care through Entrepreneurship (Part 8 of 15) June 30, The Pharmacist's Voice ® Podcast Episode 227: Interview with Jade L. Ranger, PharmD, about her book Mustard Seed Mentality: Unscripted Pearls of Wisdom from a Wife, Mother, and Entrepreneur (Part 9 of 15) July 7, The Pharmacist's Voice ® Podcast Episode 229: Interview with RDML Pam Schweitzer, PharmD and her daughter Amy Graves about their children's book Alice and Jack Hike the Grand Canyon (Part 10 of 15) July 10, The Pharmacist's Voice ® Podcast Episode 230: Interview with Cory Jenks, PharmD about his book Permission to Care:  Building a Healthcare Culture That Thrives in Chaos (Part 11 of 15) July 14, The Pharmacist's Voice ® Podcast Episode 231: Interview with Donna Bartlett, PharmD about her book MedStrong:  Shed Your Meds for a Better, Healthier You - Aging Well Through Deprescribing  (Part 12 of 15) July 17, The Pharmacist's Voice ® Podcast Episode 232:  Interview with Frieda Wiley, PharmD about her book Telecommuting Psychosis:  From Surviving to Thriving While Working in Your Pajama Pants.  Plus, we touch on her 3 children's books in development. (Part 13 of 15) July 21, The Pharmacist's Voice ® Podcast Episode 233:  Interview with Tim Ulbrich, PharmD about his book Seven Figure Pharmacist:  How to Maximize Your Income, Eliminate Debt, and Create Wealth  (Part 14 of 15) July 24, The Pharmacist's Voice ® Podcast Episode 234:  Interview with LaQuoia Johnson, PharmD about her book How Rxacism Manifests Inside the Small World of Pharmacy (Part 15 of 15) July 28, The Pharmacist's Voice ® Podcast Episode 235:  Pharmacist Authors Series wrap-up (solo show)   Kim's websites and social media links: ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF  ✅ LinkedIn Newsletter link https://bit.ly/40VmV5B ✅ Audiobook Narration Services https://www.kimnewlove.com/narration  ✅ Business website https://www.thepharmacistsvoice.com ✅ Buy my book on amazon.com https://amzn.to/4iAKNBs  ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Drug pronunciation course https://www.kimnewlove.com ✅ Podcasting Course https://www.kimnewlove.com/podcasting   ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅ Start a podcast with the same coach who helped me get started (Dave Jackson from The School of Podcasting)! **Affiliate Link - NEW 9-8-23**      Thank you for listening to episode 340 of The Pharmacist's Voice ® Podcast.  If you know someone who would like this episode, please share it with them!

Jackie Boyle returns nearly two years after paying off $200K+ in student loans to share how that milestone shaped her growth. Jackie also discusses mindset shifts, burnout in pharmacy, and her mission to help ambitious women reconnect with their purpose and potential. Episode Summary In this episode, Jackie Boyle, PharmD, returns to the YFP Podcast to share what's happened in the nearly two years since she and her husband paid off over $200,000 in student loans. Jackie and Tim Ulbrich dive into the pressure many pharmacists feel to follow a traditional career path, the mindset shifts required to break free from self-limiting beliefs, and the realities of burnout in the profession. Jackie also opens up about her journey into coaching and the mission behind Jackie Boyle Coaching, where she helps ambitious women reconnect with their purpose and potential. Whether you're feeling stuck, burned out, or questioning what's next in your career, this episode offers honest insights, encouragement, and hope for what's possible. Mentioned on the Show YFP YouTube Channel YFP 331: How One Couple Paid Off $208k of Student Loans Standard University “Imposter Syndrome” Turning Pro by Steven Pressfield The Big Leap by Gay Hendricks 10x is Easier Than 2x by Dan Sullivan Jackie Boyle Coaching   Jackie Boyle LinkedIn Profile

On this episode of Managed Care Cast, The American Journal of Managed Care® speaks with Jonathan Gabison, MD, DABOM, and Stephen Lott, PharmD, MS. At the University of Michigan, Gabison is an obesity medicine specialist and family physician, while Lott serves as director of the postgraduate year one managed care residency program and manager of the university's prescription drug plan. Their qualitative study, "Understanding Insurance Coverage Policies for Incretin Mimetics for Weight Management," determined that the high costs associated with these therapies limit insurance coverage and contribute to variation in utilization management strategies aimed at controlling short-term spending. During the conversation, the investigators discuss how high costs, misconceptions about obesity, and inconsistent coverage policies continue to hinder equitable, patient-centered care.

Send us a textSchedule an Rx AssessmentSubscribe to Master The MarginOne of the strongest forces shaping the future of independent pharmacy right now is advocacy.Many pharmacists however still underestimate their power to influence policy and protect their profession.In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, and Bonnie Bond, CPA, sit down with Dr. Steve Hoffart, PharmD, FAAFM and Owner at Magnolia Pharmacy to share real-world experiences from the front lines of pharmacy advocacy.This episode covers:Why advocacy is a critical skill for today's pharmacistsBuilding relationships with legislators to drive meaningful changeHow compounding and wellness tie into a broader advocacy missionOvercoming PBM challenges through collective actionMore About Our Guest:Steven C. Hoffart, PharmD, received his Bachelor of Science in Pharmacy with highest honors in 1994 and a Doctorate in Pharmacy from the University of Texas at Austin in 2000. He also holds a board certification and fellowship through the American Academy of Anti-Aging (A4M).In November of 2002, Dr. Hoffart saw a need for a more personal pharmacy that could make an impact in the community on a larger scale. Magnolia Pharmacy strives to best work with the "triad." The triad is a strong working relationship between the patient, physician, and pharmacy to solve medication problems and provide real solutions for patients to achieve better health and wellness. Cultivating this working relationship has ultimately produced a unique pharmacy experience for each Magnolia Pharmacy patient.Since 2002, Dr. Hoffart has received numerous awards and recognition for his dedication to the pharmacy profession.Dr. Hoffart is also a member of The International Academy for Compounding Pharmacists (IACP), National Community Pharmacists Association (NCPA), American Pharmacies buying Co-op (APRx), and the Professional Compounding Centers of America (PCCA). Always striving to achieve excellence, Magnolia Pharmacy is one of only a few dozen pharmacies in the state of Texas to be accredited by the Pharmacy Compounding Accreditation Board (PCAB).Learn more about Steven and Magnolia Pharmacy:Steven Hoffart LinkedInMagnolia Pharmacy FacebookMagnolia Pharmacy InstagramMagnolia Pharmacy TikTokMagnolia Pharmacy YouTubeMagnolia Pharmacy WebsiteStay connected with us:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterMore Resources on these Topics:Podcast – The One Big, Beautiful BillPodcast – Driving Independent Pharmacy Profitability in 2025Podcast - Momentum on the Hill: Protecting Indep

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Whitney Trotter Ross, MD, MSCI Despite advances in endometriosis treatment, bias and stigma continue to delay diagnosis and disrupt care for many patients. Informed, empathetic care is key for supporting diverse patient populations. Dr. Charles Turck sits down with Dr. Whitney Ross to unpack how historical misconceptions still influence prescribing habits and discuss actionable strategies for counseling, selecting a treatment plan, and building trust. Dr. Ross is an Assistant Professor of Obstetrics and Gynecology in the Division of Minimally Invasive Gynecologic Surgery at Washington University in St. Louis.

Mansi Shah is a former PharmD turned serial entrepreneur, retreat producer, and visionary behind The ARC — a sanctuary for transformational leadership and tribe-building. She runs multiple 7-figure businesses and co-stewards an 80-acre eco-resort in Julian, CA. Through the Alternative Investors Legacy Fund, she helps mission-driven investors create wealth while restoring the planet. Her life's work: empower founders to heal, lead, and leave a legacy through transformational experiences. You will enjoy her wisdom and our conversation for sure as we discuss her journey from India, her journey with health issues, the pharmaceutical industry truths, wealth and scarcity AND how to expand your consciousness with the help of the Divine Feminine goddesses. Learn about our women's retreat at www.MagdalenaGrace.com LEARN MORE ABOUT MANSI HERE: https://lu.ma/TheARC 7 FIND OUT MORE ABOUT MAGDALENA GRACE HERE or TO SIGN UP FOR HER UPCOMING ABUNDANCE ALCHEMIST IN PERSON WORKSHOPS OR HEALTHY N WEALTHY N WISE RETREATS Our Women's Retreat is 9/9 - Build your business and life like a Queen Our Coed retreat is Oct 17-19th BOOK A RUNES READING AND SIGN UP FOR HER WORKSHOPS & MORE! www.MagdalenaGrace.com   JOIN OUR HEALTHY N WEALTHY N WISE ONLINE ACADEMY  www.microdosingforhealth.com    BUY ME A COFFEE OR DONATE FOR SCHOLARSHIP FUND FOR HEALING CLIENTS IN NEED https://venmo.com/u/lotusthrone   MORE ALCHEMY OPPORTUNITIES FOR YOUR BEST HEALTH, WEALTH AND RELATIONSHIPS www.SanDiegoKambo.com  www.KundaliniFallbrook.com  www.LotusThroneSanctuary.com   WANNA SIGN UP AND BE A PLEDGING PATRON FOR HEALTHY N WEALTHY N WISE - SAVING LIVES AND CREATING MORE ABUNDANCE FOR OTHERS?  https://patron.podbean.com/magdalena    

We're back with another episode of Push Dose Pearls with ED Clinical Pharacist, Haley Burhans! In this episode, we break down the essentials of managing agitation in the ED—starting with why you should avoid diphenhydramine in the elderly and benzodiazepines in the 3 D's: drunk, delirium, and dementia. We discuss how to quickly assess the cause, choose the right medication, and decide between IM and IV routes. And Haley offers some key safety tips and considerations for special populations, including kids and the elderly.  Was this episode helpful? What other medications would you like to learn more about? Hit us up on social media @empulsepodcast or at ucdavisem.com Hosts: Dr. Julia Magaña, Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Professor of Emergency Medicine at UC Davis Guests: Haley Burhans, PharmD, Emergency Medicine Clinical Pharmacist at UC Davis Resources: ACEP's New Clinical Policy on Severe Agitation. By Molly E.W. Thiessen, MD, FACEP | on February 12, 2024 Pediatric Education and Advocacy Kit (PEAK): Agitation Hoffmann JA, Pergjika A, Konicek CE, Reynolds SL. Pharmacologic Management of Acute Agitation in Youth in the Emergency Department. Pediatr Emerg Care. 2021 Aug 1;37(8):417-422. doi: 10.1097/PEC.0000000000002510. PMID: 34397677; PMCID: PMC8383287. Gerson R, Malas N, Feuer V, Silver GH, Prasad R, Mroczkowski MM. Best Practices for Evaluation and Treatment of Agitated Children and Adolescents (BETA) in the Emergency Department: Consensus Statement of the American Association for Emergency Psychiatry. West J Emerg Med. 2019 Mar;20(2):409-418. doi: 10.5811/westjem.2019.1.41344. Epub 2019 Feb 19. Erratum in: West J Emerg Med. 2019 May;20(3):537. doi: 10.5811/westjem.2019.4.43550. Erratum in: West J Emerg Med. 2019 Jul;20(4):688-689. doi: 10.5811/westjem.2019.4.44160. PMID: 30881565; PMCID: PMC6404720.. **** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services.

What happens when patients can't afford the medicine you've worked so hard to create? In this episode, host Elaine Hamm, PhD, sits down with Vinay Patel, PharmD—Chief Pharmacy Officer at Proactive MD and Founder of MakoRx—to unpack the hidden complexities behind drug pricing, access, and affordability. Together, they explore how traditional insurance models impact patient care, and what drug developers and startups need to know to ensure their therapeutics actually reach the people who need them. In this episode, you'll discover: Why pharmacy benefit managers (PBMs) influence drug access—and what that means for your commercialization strategy. How cost-plus pricing models are changing the healthcare landscape. Key considerations for biotech innovators to ensure affordability, patient access, and long-term success. Whether you're developing a new therapeutic or trying to understand the real-world implications of drug pricing, this conversation offers a powerful look behind the pharmacy counter. Links: Connect with Vinay Patel, PharmD, and check out Proactive MD and MakoRx. Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine. Learn more about The Study, Elaine's wine bar. Connect with Ian McLachlan, BIO from the BAYOU producer. Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025. Learn more about BIO from the BAYOU - the podcast. Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

In this episode, James Davis, PharmD, BCOP and Victoria Nachar, PharmD, BCOP summarize the latest key clinical updates on BTK inhibitors in CLL based on data recently presented at the annual ASCO and EHA meetings, including:The randomized phase III FLAIR trialThe randomized phase III SEQUOIA trialThe randomized phase III BRUIN CLL-321 trial Presenters:James Davis, PharmD, BCOPClinical Pharmacy Specialist, Malignant HematologyMUSC Hollings Cancer CenterAssistant ProfessorMUSC College of PharmacyCharleston, South CarolinaVictoria Nachar, PharmD, BCOPClinical Pharmacist Specialist, HematologyUniversity of Michigan Rogel Cancer CenterAnn Arbor, MichiganLink to full program: https://bit.ly/3H2EcSX

In this episode, our guest is Heidi Steinecker, DrPH & Principal of Health & Human Services Consulting at Resultant. With over two decades of leadership in public health and healthcare systems—including as Deputy Director of the California Department of Public Health—Heidi is helping states transform how they use data to prevent crises and protect vulnerable communities.Heidi takes complex public health challenges and breaks them down into clear, data-driven strategies that work. She's spent her career modernizing outdated systems, leading emergency responses, and designing early intervention models that save lives. Today at Resultant—recently named one of Fast Company's Most Innovative Companies of 2025—Heidi is focused on helping agencies turn massive amounts of public health data into actionable, equitable solutions.Heidi, welcome to the Talk to Your Pharmacist podcast. Now that our listeners have heard a bit about your background maybe you can fill in any gaps to that intro and share a bit about your personal life.Topics to discuss --How public health agencies can move from reactive to proactive using predictive analyticsWhy modernizing health data systems is no longer optional—and how to get startedFrom Classroom to Policy Leadership – before becoming California's Deputy Director of Public Health during the COVID‑19 pandemic How did your early experiences in teaching inform your approach to leadership and communication during a public health crisis?Leading Transformation at Scale – At CDPH, you transformed manual inspection systems into proactive, cloud‑based predictive models Can you discuss a specific challenge you faced transitioning these systems, and how you overcame resistance to change?Bridging Local and Global Health – Your doctoral work at MCW focused on infectious diseases in high-risk settings and you emphasize “local health is global health” How do you translate lessons learned in global health contexts to strengthen health systems here in the U.S.?Modernizing Public Health Infrastructure – In a recent podcast, you emphasized that modernization starts with relationships—combined with tech like AI and predictive analytics.What are the critical steps to building both the relational and technical foundations needed for effective public health modernization?Guest - Heidi Steineckerhttps://www.linkedin.com/in/heidiwsteinecker/Host - Hillary Blackburn, PharmD, MBAwww.hillaryblackburn.comhttps://www.linkedin.com/in/hillary-blackburn-67a92421/  ★ Support this podcast on Patreon ★

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features Mariah Hollabaugh, director of pharmacy at Citizens Memorial Hospital, Hayle Gillespie, medication access specialist at Citizens Memorial Hospital, and Jodie Gregg, an advocate and patient. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This week's TWIRx puts the pedal to the metal—literally. Host Todd Eury dives into the surprising parallels between racing 150+ MPH and building a pharmacy business from the ground up. Special guest Charles Hoopes, co-owner of S&H Motorsports, joins the show alongside Stephen Beckman, CEO of YARAL Pharma, to preview the upcoming “Geezer Race” on Saturday, July 19th, sponsored by YARAL. Charles shares the intense highs and lows of becoming a drag racing team owner—from financial risk to the emotional rollercoaster of chasing a dream. His story mirrors the grit and resilience required to own and operate an independent pharmacy today.

Send us a textSchedule an Rx AssessmentSubscribe to Master The MarginOut of all the hats that pharmacy owners need to wear, advocacy is arguably one of the most important. Yet too many pharmacy owners underestimate their ability to influence meaningful change.So how can pharmacy leaders advocate effectively and ensure their voices are heard in critical policy discussions?In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, and Bonnie Bond, CPA, sit down with Dr. Cole Sandlin, PharmD and Owner of Fred's Pharmacies to break down: The key takeaways from the pharmacy fly-inHow bipartisan support is driving momentum for pharmacy initiativeThe role of AI in strengthening pharmacy operationsAnd more!More About Our Guest:Cole Sandlin, PharmD is a 2008 graduate of Samford University McWhorter School of Pharmacy and the owner of Fred's Pharmacy in Hamilton, Alabama.Growing up in Hamilton, his grandfather, Fred C. Sandlin, founded Fred's Pharmacy in 1951. Cole's father, Fred Jr., took over from his dad and in 2014 Cole and wife Jill bought the pharmacy from his dad.   Learn more about Cole and Fred's Pharmacies:Cole Sandlin LinkedInFred's Pharmacies WebsiteFred's Pharmacies InstagramStay connected with us:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP Twitter More Resources on these Topics:Podcast – The One Big, Beautiful BillPodcast – Driving Independent Pharmacy Profitability in 2025Podcast - AI, Audits, & Advocacy: The Pharmacy Survival GuidePodcast - Pharmacy Advocacy: Going Beyond Patient Care for Your Community

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joined Over the Counter to discuss the importance of insulin delivery and how advancements in this space are expected to improve diabetes outcomes.

Join Drs. Neil Skolnik and Sara Wettergreen as they discuss key takeaways from the ADA's 85th Scientific Sessions in Chicago, highlighting advancements in diabetes and obesity care. With guests, Drs. Osagie Ebekozien and Marlon Pragnell, they'll explore how these advancements can positively impact you and your loved ones.   Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Osagie Ebekozien, MD, MPH, CPHQ, Chief Quality Officer at the ADA  Marlon Pragnell, PhD, Vice President of Research and Science at the ADA Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Additional resources: Patient Standards of Care 2025 Need information on diabetes, ADA programs, or upcoming events? The ADA's Center for Information is here to help. Contact them directly at 1-800-DIABETES (1-800-342-2383) or email AskADA@diabetes.org for personalized guidance and support.

On this episode, we evaluate current guidelines and evidence-based treatment strategies for managing insomnia, including both pharmacological and non-pharmacological approaches. We compare and contrast the efficacy, safety profiles, and appropriate use of pharmacologic agents, behavioral therapies, and lifestyle interventions for treating insomnia.  Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Artificial intelligence (AI) will bring many opportunities to the pharmacy profession, but it can be tempting to use AI in place of critical thinking or reliable research around drug information questions (DIQs). One must wonder, will the pharmacist be held liable if AI gets it wrong? Guest Authors: Elizabeth B. Hearn, PharmD, BCACP, CDCES; Karlyn E. Hood, PharmD, BCPS; Abigail L. Torres, PharmD Music by Good Talk

The latest episode of the Astonishing Healthcare podcast dives into the functionalities and real-world impact of Rx Smart Save, a low-cost alternative program designed to reduce medication costs for both patients and plan sponsors. Jackie Lolos, PharmD, and Haleh (Halls) Campbell, PharmD, join Justin Venneri in the studio for a discussion highlighting the innovation and care behind this clinical program.Jackie and Halls outline how the two levels of Rx Smart Save work, with Level 1 empowering members to independently switch to lower-cost, clinically equivalent medications via notifications on the Capital Rx app or web portal. Level 2 increases access with a proactive, high-touch approach, where a team of pharmacists and specialists assist members, prescribers, and pharmacies throughout the process. Halls also shares a quick case study demonstrating how one retiree saved $75 per prescription by switching from an injection-based migraine treatment to a tablet, and Jackie explains how modern technology aids the process..Related ContentAH035 - Pharmacy Benefits 101: Clinical Programs, with Bonnie Hui-Callahan, PharmDPharmacy Benefits 101: Building an Award-Winning Call Center from ScratchAH006 - Pharmacy Benefits 101: Clinical Care Teams, with Amy Stockton, PharmDSigns it is time to change your PBM vendor, and how to overcome common hesitations (Capital Rx / Benefits Pro)For more information about Capital Rx and this episode, please visit Capital Rx Insights.

Wondering whether to contribute to a Roth or Traditional retirement account? Tim Ulbrich and Tim Baker break down key factors like tax brackets, Roth 401(k) access, and long-term planning tips to help you decide. Episode Summary One of the most common questions we get is: Should I contribute to a Roth or Traditional retirement account? In this episode, YFP Co-Founder & CEO, Tim Ulbrich, PharmD, and YFP Co-Founder & COO, Tim Baker, CFP®, RLP®, RICP®, break down the key factors to consider when deciding between Roth and Traditional contributions, including: ✅ Your current and projected future tax bracket ✅ How much you've already saved in each account type ✅ Roth 401(k) availability through your employer ✅ State income tax implications ✅ Whether you have the cash flexibility to consider Roth conversions ✅ How the Roth IRA's freedom from required minimum distributions (RMDs) can be a valuable planning tool If you've ever found yourself wondering which retirement bucket to prioritize, or if you're simply trying to be more tax-savvy with your savings, this episode is for you.

Master the latest approaches for treating venous thromboembolism with expert tips on direct oral anticoagulant (DOAC) selection, dosing, and duration. Learn how to tailor anticoagulation for special populations, handle treatment failures, and navigate long-distance travel risks. We're joined by Dr. Tara Lech, PharmD, CACP (Beth Israel Lahey Health, @AnticoagPharmD, @anticoagpharmd.bsky.social‬). Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro Case 1 from Kashlak Choosing the right anticoagulant Distal deep vein thrombosis management Anticoagulation in special populations Case 2 from Kashlak Understanding treatment failure Anticoagulation reversal agents Outro Credits Producer, Writer, Show Notes, Infographic, Cover Art: Ben Furman  Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Leah Witt, MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Tara Lech, PharmD  Disclosures Dr. Lech reports no relevant financial disclosures. The Curbsiders report no relevant financial disclosures.  Sponsor: Grammarly  Let Grammarly take the busywork off your plate so you can focus on high-impact work. Download Grammarly for free at Grammarly.com/PODCAST. Sponsor: Freed CURB50 to get $50 off your first month when you subscribe at freed.ai Sponsor: JournalFeed Try JournalFeed free for 7 days—and get 20% off your first year with code CURB25 at journalfeed.org/curb. 

Thinking about changing jobs or just got promoted? In this episode, Tim and Tim cover 7 key financial considerations, from negotiating offers to managing benefits, to help you navigate the transition with clarity and confidence. Episode Summary If you recently changed jobs or just landed a promotion, congratulations! A new opportunity, whether internal or external, often brings exciting possibilities…and important financial decisions. In this episode, 7 Key Financial Considerations During a Job Transition, YFP Co-Founder & CEO, Tim Ulbrich, PharmD is joined by YFP Co-Founder & COO, Tim Baker, CFP®, RLP®, RICP® to walk you through the most important financial areas to think about when navigating a job change or stepping into a new role. They cover how to: ✅ Evaluate and negotiate a new offer ✅ Understand your updated benefits package ✅ Make a plan for your old 401(k) ✅ Align your new compensation with your financial goals ...and more. Whether you're in the early stages of a transition or already in your new role, this episode is your financial checklist to move forward with clarity and confidence. Mentioned on the Show YFP 384: Beyond Salary: Negotiating Your Value in the Workplace Never Split the Difference by Chris Voss YFP 328: How to Navigate Open Enrollment & Employer Benefits YFP Episode 408: What Should You Do With an Old 401(k) YFP Episode 404: 5 Key Questions to Ask When Hiring a Financial Planner  

Dr. Meg Mill is a PharmD and Functional Medicine expert, specializing in neuro-digestion and its profound impact on overall health. Her renowned 3 R Protocol - Regulate, Repair, and Rewire - offers a holistic approach to improving both physical and mental well-being. A bestselling author and frequent media contributor, Dr. Meg has been featured on major networks and in leading publications, sharing her expertise with audiences worldwide. CONNECT WITH HER https://megmill.com Subscribe to this channel now!  https://www.youtube.com/user/lunidelouis/?sub_confirmation=1    ---------------------------------------------------- Join our exclusive Facebook group @ https://www.facebook.com/groups/339709559955223  --------------------------------------------------- Looking for accountability to do your morning routine -- join us tomorrow morning, it's FREE:   https://bestmorningroutineever.com/  ----------------------------------------­­­­­­­-------------